Aclaris Therapeutics files 8-K furnishing updated corporate overview; no new financial data disclosed

Aclaris Therapeutics, Inc.

Filed Form 8-K on Jan. 12, 2026, updating its corporate overview presentation (Exhibit 99.1).
Presentation available on company website; no specific financial or operational changes provided in filing.
No earnings, guidance, clinical results, or other material events disclosed in the filing or exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.